1. Home
  2. PKST vs ALT Comparison

PKST vs ALT Comparison

Compare PKST & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PKST
  • ALT
  • Stock Information
  • Founded
  • PKST 2008
  • ALT 1997
  • Country
  • PKST United States
  • ALT United States
  • Employees
  • PKST N/A
  • ALT N/A
  • Industry
  • PKST Real Estate Investment Trusts
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • PKST Real Estate
  • ALT Health Care
  • Exchange
  • PKST Nasdaq
  • ALT Nasdaq
  • Market Cap
  • PKST 419.1M
  • ALT 472.3M
  • IPO Year
  • PKST N/A
  • ALT N/A
  • Fundamental
  • Price
  • PKST $12.01
  • ALT $5.76
  • Analyst Decision
  • PKST Buy
  • ALT Strong Buy
  • Analyst Count
  • PKST 2
  • ALT 7
  • Target Price
  • PKST $15.00
  • ALT $21.00
  • AVG Volume (30 Days)
  • PKST 125.5K
  • ALT 2.2M
  • Earning Date
  • PKST 05-08-2025
  • ALT 05-13-2025
  • Dividend Yield
  • PKST 7.48%
  • ALT N/A
  • EPS Growth
  • PKST N/A
  • ALT N/A
  • EPS
  • PKST N/A
  • ALT N/A
  • Revenue
  • PKST $225,817,000.00
  • ALT $20,000.00
  • Revenue This Year
  • PKST N/A
  • ALT N/A
  • Revenue Next Year
  • PKST N/A
  • ALT N/A
  • P/E Ratio
  • PKST N/A
  • ALT N/A
  • Revenue Growth
  • PKST 5.64
  • ALT N/A
  • 52 Week Low
  • PKST $9.89
  • ALT $3.55
  • 52 Week High
  • PKST $16.26
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • PKST 55.16
  • ALT 57.44
  • Support Level
  • PKST $10.80
  • ALT $4.95
  • Resistance Level
  • PKST $12.29
  • ALT $6.05
  • Average True Range (ATR)
  • PKST 0.46
  • ALT 0.40
  • MACD
  • PKST 0.04
  • ALT 0.11
  • Stochastic Oscillator
  • PKST 71.98
  • ALT 69.42

About PKST Peakstone Realty Trust

Peakstone Realty Trust is an internally managed, publicly registered real estate investment trust (REIT) that owns and operates predominately single-tenant industrial and office properties with creditworthy tenants and long-term leases. Peakstone's portfolio consists of newer vintage, and well-located real estate assets in majorly high-growth coastal and sunbelt markets. The company has two reportable segments: Industrial and Office. The Industrial segment consists of industrial outdoor storage properties which have a low building-to-land ratio, or low coverage, maximizing yard space for the display, movement, and storage of materials and equipment. The Office segment includes office, R&D and data center properties.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: